Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 330

1.

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study.

Jeffery MM, Hooten WM, Henk HJ, Bellolio MF, Hess EP, Meara E, Ross JS, Shah ND.

BMJ. 2018 Aug 1;362:k2833. doi: 10.1136/bmj.k2833.

2.

Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs.

Liu P, Dhruva SS, Shah ND, Ross JS.

Ann Intern Med. 2018 Jul 24. doi: 10.7326/M18-0965. [Epub ahead of print] No abstract available.

PMID:
30039170
3.

Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation.

Afrough A, Saliba RM, Hamdi A, Honhar M, Varma A, Cornelison AM, Rondon G, Parmar S, Shah ND, Bashir Q, Hosing C, Popat U, Weber DM, Thomas S, Orlowski RZ, Champlin RE, Qazilbash MH.

Biol Blood Marrow Transplant. 2018 Aug 8. pii: S1083-8791(18)30397-5. doi: 10.1016/j.bbmt.2018.07.010. [Epub ahead of print]

PMID:
30016656
4.

Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States.

Siontis KC, Zhang X, Eckard A, Bhave N, Schaubel DE, He K, Tilea A, Stack AG, Balkrishnan R, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK.

Circulation. 2018 Jun 28. pii: CIRCULATIONAHA.118.035418. doi: 10.1161/CIRCULATIONAHA.118.035418. [Epub ahead of print]

PMID:
29954737
5.

High rates of cancer screening among dialysis patients seen in primary care a cohort study.

Thorsteinsdottir B, Hickson LJ, Ramar P, Reinalda M, Krueger NW, Crowson CS, Rule AD, Takahashi PY, Chaudhry R, Tulledge-Scheitel SM, Tilburt JC, Williams AW, Albright RC, Meier SK, Shah ND.

Prev Med Rep. 2018 Mar 14;10:176-183. doi: 10.1016/j.pmedr.2018.03.006. eCollection 2018 Jun.

6.

Big Data and Predictive Analytics: Recalibrating Expectations.

Shah ND, Steyerberg EW, Kent DM.

JAMA. 2018 Jul 3;320(1):27-28. doi: 10.1001/jama.2018.5602. No abstract available.

PMID:
29813156
7.

Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery.

Yao X, Gersh BJ, Holmes DR Jr, Melduni RM, Johnsrud DO, Sangaralingham LR, Shah ND, Noseworthy PA.

JAMA. 2018 May 22;319(20):2116-2126. doi: 10.1001/jama.2018.6024.

PMID:
29800182
8.

Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients.

Shah ND, Shah PS, Panchal YY, Katudia KH, Khatri NB, Ray HSP, Bhatiya UR, Shah SC, Shah BS, Rao MV.

Appl Clin Genet. 2018 May 9;11:59-67. doi: 10.2147/TACG.S155955. eCollection 2018.

9.

Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulation.

Yao X, Gersh BJ, Sangaralingham LR, Shah ND, Noseworthy PA.

Am Heart J. 2018 May;199:137-143. doi: 10.1016/j.ahj.2018.02.005. Epub 2018 Feb 10.

PMID:
29754652
10.

Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors.

Ruddy KJ, Sangaralingham L, Freedman RA, Mougalian S, Neuman H, Greenberg C, Jemal A, Duma N, Haddad TC, Lemaine V, Ghosh K, Hieken TJ, Hunt K, Vachon C, Gross C, Shah ND.

J Natl Compr Canc Netw. 2018 May;16(5):526-534. doi: 10.6004/jnccn.2018.7001.

PMID:
29752327
11.

Recurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes.

McCoy RG, Herrin J, Lipska KJ, Shah ND.

J Diabetes Complications. 2018 Jul;32(7):693-701. doi: 10.1016/j.jdiacomp.2018.04.007. Epub 2018 Apr 24.

PMID:
29751961
12.

National trends in emergency department visits and hospitalizations for food-induced anaphylaxis in US children.

Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Campbell RL.

Pediatr Allergy Immunol. 2018 Apr 17. doi: 10.1111/pai.12908. [Epub ahead of print]

PMID:
29663520
13.

Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset.

Goyal G, Bartley AC, Funni S, Inselman J, Shah ND, Marshall AL, Ashrani AA, Kapoor P, Durani U, Hashmi SK, Siddiqui MA, Buadi FK, Go RS, Kyle RA, Kumar S, Gonsalves WI.

Leukemia. 2018 Jun;32(6):1414-1420. doi: 10.1038/s41375-018-0099-8. Epub 2018 Mar 21.

PMID:
29654264
14.

Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis.

Yalniz FF, Murad MH, Lee SJ, Pavletic SZ, Khera N, Shah ND, Hashmi SK.

Biol Blood Marrow Transplant. 2018 Mar 14. pii: S1083-8791(18)30121-6. doi: 10.1016/j.bbmt.2018.03.008. [Epub ahead of print]

PMID:
29550629
15.

Access to primary care and computed tomography use in the emergency department.

Bellolio MF, Bellew SD, Sangaralingham LR, Campbell RL, Cabrera D, Jeffery MM, Shah ND, Hess EP.

BMC Health Serv Res. 2018 Mar 2;18(1):154. doi: 10.1186/s12913-018-2958-4.

16.

Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

Sangaralingham LR, Sangaralingham SJ, Shah ND, Yao X, Dunlay SM.

Circ Heart Fail. 2018 Feb;11(2):e004302. doi: 10.1161/CIRCHEARTFAILURE.117.004302.

PMID:
29453287
17.

Associations of inflammation with symptom burden in patients with acute myeloid leukemia.

Lacourt TE, Kavelaars A, Galloway-Peña JR, Sahasrabhojane PV, Shah ND, Futreal A, Kontoyiannis DP, Shelburne SA, Heijnen CJ.

Psychoneuroendocrinology. 2018 Mar;89:203-208. doi: 10.1016/j.psyneuen.2018.01.018.

PMID:
29414033
18.

Hospital Readmission among New Dialysis Patients Associated with Young Age and Poor Functional Status.

Hickson LJ, Thorsteinsdottir B, Ramar P, Reinalda MS, Crowson CS, Williams AW, Albright RC, Onuigbo MA, Rule AD, Shah ND.

Nephron. 2018;139(1):1-12. doi: 10.1159/000485985. Epub 2018 Jan 9.

PMID:
29402792
19.

Comparative Assessment of Patient Preferences and Tolerability in Barrett Esophagus Screening: Results From a Randomized Trial.

Blevins CH, Egginton JS, Shah ND, Johnson ML, Iyer PG.

J Clin Gastroenterol. 2018 Jan 23. doi: 10.1097/MCG.0000000000000991. [Epub ahead of print]

PMID:
29369237
20.

Endoscopic ultrasound and the liver: current applications and beyond.

Shah ND, Baron TH.

J Hepatobiliary Pancreat Sci. 2018 Mar;25(3):171-180. doi: 10.1002/jhbp.528. Epub 2018 Jan 15. Review.

PMID:
29334698
21.

Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: determining demographic differences in the USA.

Go RS, Heien HC, Sangaralingham LR, Habermann EB, Shah ND.

Haematologica. 2018 Mar;103(3):e123-e125. doi: 10.3324/haematol.2017.179978. Epub 2017 Dec 21. No abstract available.

22.

Impact of a Shared Decision Making Intervention on Health Care Utilization: A Secondary Analysis of the Chest Pain Choice Multicenter Randomized Trial.

Schaffer JT, Hess EP, Hollander JE, Kline JA, Torres CA, Diercks DB, Jones R, Owen KP, Meisel ZF, Demers M, Leblanc A, Inselman J, Herrin J, Montori VM, Shah ND.

Acad Emerg Med. 2018 Mar;25(3):293-300. doi: 10.1111/acem.13355. Epub 2017 Dec 26.

PMID:
29218817
23.

Prevalence and factors associated with gluten sensitivity in inflammatory bowel disease.

Limketkai BN, Sepulveda R, Hing T, Shah ND, Choe M, Limsui D, Shah S.

Scand J Gastroenterol. 2018 Feb;53(2):147-151. doi: 10.1080/00365521.2017.1409364. Epub 2017 Dec 7.

PMID:
29216767
24.

New and incremental FDA black box warnings from 2008 to 2015.

Solotke MT, Dhruva SS, Downing NS, Shah ND, Ross JS.

Expert Opin Drug Saf. 2018 Feb;17(2):117-123. doi: 10.1080/14740338.2018.1415323. Epub 2017 Dec 17.

25.

Reply: NOAC Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.

Yao X, Shah ND, Sangaralingham LR, Gersh BJ, Noseworthy PA.

J Am Coll Cardiol. 2017 Nov 28;70(21):2734-2735. doi: 10.1016/j.jacc.2017.09.1092. No abstract available.

PMID:
29169488
26.

Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.

Yao X, Tangri N, Gersh BJ, Sangaralingham LR, Shah ND, Nath KA, Noseworthy PA.

J Am Coll Cardiol. 2017 Nov 28;70(21):2621-2632. doi: 10.1016/j.jacc.2017.09.1087.

PMID:
29169468
27.

Increasing Trends in the Use of Hospital Observation Services for Older Medicare Advantage and Privately Insured Patients.

Lind KD, Noel-Miller CM, Sangaralingham LR, Shah ND, Hess EP, Morin P, Fernanda Bellolio M.

Med Care Res Rev. 2017 Jul 1:1077558717718026. doi: 10.1177/1077558717718026. [Epub ahead of print]

PMID:
29148348
28.

Association between FDA black box warnings and Medicare formulary coverage changes.

Dhruva SS, Karaca-Mandic P, Shah ND, Shaw DL, Ross JS.

Am J Manag Care. 2017 Sep 1;23(9):e310-e315.

29.

Care of the dialysis patient: Primary provider involvement and resource utilization patterns - a cohort study.

Thorsteinsdottir B, Ramar P, Hickson LJ, Reinalda MS, Albright RC, Tilburt JC, Williams AW, Takahashi PY, Jeffery MM, Shah ND.

BMC Nephrol. 2017 Oct 25;18(1):322. doi: 10.1186/s12882-017-0728-x.

30.

Characteristics of Novel Therapeutics and Postmarket Safety Events-Reply.

Downing NS, Shah ND, Ross JS.

JAMA. 2017 Sep 19;318(11):1067-1068. doi: 10.1001/jama.2017.11517. No abstract available.

PMID:
28975302
31.

Opioid Prescribing for Opioid-Naive Patients in Emergency Departments and Other Settings: Characteristics of Prescriptions and Association With Long-Term Use.

Jeffery MM, Hooten WM, Hess EP, Meara ER, Ross JS, Henk HJ, Borgundvaag B, Shah ND, Bellolio MF.

Ann Emerg Med. 2018 Mar;71(3):326-336.e19. doi: 10.1016/j.annemergmed.2017.08.042. Epub 2017 Sep 26.

32.

Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.

Kunneman M, Branda ME, Noseworthy PA, Linzer M, Burnett B, Dick S, Spencer-Bonilla G, Fernandez CA, Gorr H, Wambua M, Keune S, Zeballos-Palacios C, Hargraves I, Shah ND, Montori VM.

Trials. 2017 Sep 29;18(1):443. doi: 10.1186/s13063-017-2178-y.

33.

Trends in Omalizumab Utilization for Asthma: Evidence of Suboptimal Patient Selection.

Jeffery MM, Shah ND, Karaca-Mandic P, Ross JS, Rank MA.

J Allergy Clin Immunol Pract. 2017 Sep 22. pii: S2213-2198(17)30559-7. doi: 10.1016/j.jaip.2017.07.034. [Epub ahead of print]

PMID:
28958746
34.

Risk factors for severe anaphylaxis in the United States.

Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Campbell RL.

Ann Allergy Asthma Immunol. 2017 Oct;119(4):356-361.e2. doi: 10.1016/j.anai.2017.07.014.

PMID:
28958375
35.

Feeding Tubes and Health Care Service Utilization in Amyotrophic Lateral Sclerosis: Benefits and Limits to a Retrospective, Multicenter Study Using Big Data.

Swetz KM, Peterson SM, Sangaralingham LR, Hurt RT, Dunlay SM, Shah ND, Tilburt JC.

Inquiry. 2017 Jan 1;54:46958017732424. doi: 10.1177/0046958017732424.

36.

Outcomes of Emergency Department Anaphylaxis Visits from 2005 to 2014.

Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Li JT, Campbell RL.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):1002-1009.e2. doi: 10.1016/j.jaip.2017.07.041. Epub 2017 Sep 20.

PMID:
28941671
37.

Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients.

Waddle MR, Sio TT, Van Houten HK, Foote RL, Keole SR, Schild SE, Laack N, Daniels TB, Crown W, Shah ND, Miller RC.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1078-1082. doi: 10.1016/j.ijrobp.2017.07.042. Epub 2017 Aug 2.

PMID:
28939229
38.

Trajectories of Glycemic Change in a National Cohort of Adults With Previously Controlled Type 2 Diabetes.

McCoy RG, Ngufor C, Van Houten HK, Caffo B, Shah ND.

Med Care. 2017 Nov;55(11):956-964. doi: 10.1097/MLR.0000000000000807.

PMID:
28922296
39.

Predictors of epinephrine dispensing and allergy follow-up after emergency department visit for anaphylaxis.

Motosue M, Bellolio MF, Van Houten HK, Shah ND, Campbell RL.

Ann Allergy Asthma Immunol. 2017 Nov;119(5):452-458.e1. doi: 10.1016/j.anai.2017.08.005. Epub 2017 Sep 12.

PMID:
28916424
40.

In-Hospital Outcomes of Tumor Lysis Syndrome: A Population-Based Study Using the National Inpatient Sample.

Durani U, Shah ND, Go RS.

Oncologist. 2017 Dec;22(12):1506-1509. doi: 10.1634/theoncologist.2017-0147. Epub 2017 Sep 13.

PMID:
28904174
41.

Increased Computed Tomography Utilization in the Emergency Department and Its Association with Hospital Admission.

Bellolio MF, Heien HC, Sangaralingham LR, Jeffery MM, Campbell RL, Cabrera D, Shah ND, Hess EP.

West J Emerg Med. 2017 Aug;18(5):835-845. doi: 10.5811/westjem.2017.5.34152. Epub 2017 Jul 19.

42.

Baseline characteristics and event rates among anticoagulated patients with atrial fibrillation in practice and pivotal NOAC trials.

Noseworthy PA, Yao X, Gersh BJ, Hargraves I, Shah ND, Montori VM.

Data Brief. 2017 Aug 9;14:563-565. doi: 10.1016/j.dib.2017.08.010. eCollection 2017 Oct.

43.

Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.

Yao X, Gersh BJ, Sangaralingham LR, Kent DM, Shah ND, Abraham NS, Noseworthy PA.

Am J Cardiol. 2017 Nov 1;120(9):1549-1556. doi: 10.1016/j.amjcard.2017.07.051. Epub 2017 Jul 31.

PMID:
28844514
44.

Temporal Trends in Epinephrine Dispensing and Allergy/Immunology Follow-up Among Emergency Department Anaphylaxis Patients in the United States, 2005-2014.

Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Bellamkonda VR, Nestler DM, Campbell RL.

J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1272-1279.e1. doi: 10.1016/j.jaip.2017.06.009. Epub 2017 Jul 26.

PMID:
28756081
45.

Measurement with a wink.

Kunneman M, Montori VM, Shah ND.

BMJ Qual Saf. 2017 Oct;26(10):849-851. doi: 10.1136/bmjqs-2017-006814. Epub 2017 Jul 21. No abstract available.

46.

Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.

Noseworthy PA, Yao X, Gersh BJ, Hargraves I, Shah ND, Montori VM.

Int J Cardiol. 2017 Oct 15;245:174-177. doi: 10.1016/j.ijcard.2017.07.043. Epub 2017 Jul 14.

PMID:
28733071
47.

Hospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events.

McCoy RG, Lipska KJ, Herrin J, Jeffery MM, Krumholz HM, Shah ND.

J Gen Intern Med. 2017 Oct;32(10):1097-1105. doi: 10.1007/s11606-017-4095-x. Epub 2017 Jul 6.

PMID:
28685482
48.

Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.

Yao X, Shah ND, Sangaralingham LR, Gersh BJ, Noseworthy PA.

J Am Coll Cardiol. 2017 Jun 13;69(23):2779-2790. doi: 10.1016/j.jacc.2017.03.600.

49.

Mutation analysis of β-thalassemia in East-Western Indian population: a recent molecular approach.

Shah PS, Shah ND, Ray HSP, Khatri NB, Vaghasia KK, Raval RJ, Shah SC, Rao MV.

Appl Clin Genet. 2017 May 11;10:27-35. doi: 10.2147/TACG.S127531. eCollection 2017.

50.

Effectiveness of a Decision Aid in Potentially Vulnerable Patients: A Secondary Analysis of the Chest Pain Choice Multicenter Randomized Trial.

Rising KL, Hollander JE, Schaffer JT, Kline JA, Torres CA, Diercks DB, Jones R, Owen KP, Meisel ZF, Demers M, Leblanc A, Shah ND, Inselman J, Herrin J, Montori VM, Hess EP.

Med Decis Making. 2018 Jan;38(1):69-78. doi: 10.1177/0272989X17706363. Epub 2017 May 19.

PMID:
28525723

Supplemental Content

Support Center